Kane Biotech Inc. (KNE.V)

CAD 0.1

(0.0%)

Inventory Summary of Kane Biotech Inc.

  • Kane Biotech Inc.'s latest annual inventory in 2023 was 250.41 Thousand CAD , down -67.2% from previous year.
  • Kane Biotech Inc.'s latest quarterly inventory in 2024 Q2 was 727.65 Thousand CAD , up 199.68% from previous quarter.
  • Kane Biotech Inc. reported annual inventory of 763.47 Thousand CAD in 2022, up 47.04% from previous year.
  • Kane Biotech Inc. reported annual inventory of 519.22 Thousand CAD in 2021, up 10.02% from previous year.
  • Kane Biotech Inc. reported quarterly inventory of 727.65 Thousand CAD for 2024 Q2, up 199.68% from previous quarter.
  • Kane Biotech Inc. reported quarterly inventory of 250.41 Thousand CAD for 2023 Q4, down -66.86% from previous quarter.

Annual Inventory Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Inventory of Kane Biotech Inc. (2023 - 2003)

Year Inventory Inventory Growth
2023 250.41 Thousand CAD -67.2%
2022 763.47 Thousand CAD 47.04%
2021 519.22 Thousand CAD 10.02%
2020 471.93 Thousand CAD -19.61%
2019 587.03 Thousand CAD 80.93%
2018 324.45 Thousand CAD 140.06%
2017 135.15 Thousand CAD -36.76%
2016 213.71 Thousand CAD 235.36%
2015 63.72 Thousand CAD 144.77%
2014 26.03 Thousand CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD -100.0%
2004 5800.00 CAD 0.0%
2003 - CAD 0.0%

Peer Inventory Comparison of Kane Biotech Inc.

Name Inventory Inventory Difference
Arch Biopartners Inc. - CAD -Infinity%
Covalon Technologies Ltd. 5.94 Million CAD 95.787%
Hemostemix Inc. - CAD -Infinity%
Universal Ibogaine Inc. - CAD -Infinity%
MedMira Inc. 182.42 Thousand CAD -37.272%
Marvel Biosciences Corp. - CAD -Infinity%
NervGen Pharma Corp. - CAD -Infinity%
XORTX Therapeutics Inc. - CAD -Infinity%